Mexico: The Latest on COVID-19 and Vaccination Measures

22 March 2021 Coronavirus Resource Center:Back to Business Blog
Authors: Alejandro N Gomez-Strozzi Javier Valenzuela Padilla

As soon as the Mexican Ministry of Health approved the first emergency-use authorization for a COVID vaccine in December of 2020, the National Vaccination Plan immediately followed.

National Vaccination Plan

The Mexican Government has laid out the calendar of the country´s vaccination schedule (progress to date casts doubt upon whether the following is achievable):


STAGES  FORESEEN DATES  POPULATION GROUP
December 2020 - February 2021  Health workers dealing with COVID 
2 February - April 2021  Other health workers and people 60+ years of age 
April - May 2021  People 50-59 years old 
May - June 2021  People 40-49 years old 
June 2021 - March 2022  People 19-39 years old (vaccine cannot be given to children up to 18 years of age) 

In order to execute the above, the Ministry of Health established special brigades to coordinate and provide support throughout Mexico. There is a special brigade for each of the Mexican States, whose director is responsible for their operational strategy and who may require the support of State and Municipal authorities, as well as professionals and sanitary-disciplines experts and assistants.

For distribution activities, the Ministry of Health has obtained the support of the Armed Forces and the National Guard.

Which vaccines have been authorized in Mexico so far?

The Mexican Government has authorized the following vaccines:

  • BNT162b2 by Pfizer, Inc./BioNTech (December 11, 2020)

     

  • AZD1222 by AstraZeneca/Oxford University (January 4, 2021)

     

  • Sputnik V by the Gamaleya Institute (February 2, 2021)

     

  • Ad5-nCoV by CanSinoBiologics Inc. (February 9, 2021)

     

  • CoronaVac by Sinovac Research and Development Co. (February 9, 2021)

In addition, vaccines from Janssen/Johnson & Johnson, CureVac AG, and Novavax, Inc. are being evaluated by Mexican health authorities.

Who can actively participate in the National Vaccination Plan?

On January 25, 2021, the Ministry of Health issued an Executive Order allowing third parties to participate in the execution of the National Vaccination Plan.

For such purpose, State governments and private entities and individuals related to Mexico's National Health Systemare allowed to participate in the acquisition, import, distribution and application of COVID-19 vaccines in Mexico, as long as the following conditions are met:

  1. Provide the Ministry of Health with the purchase agreements entered into with pharmaceutical companies authorized by the Mexican Government;

     

  2. Inform the Ministry of Health on the amount of vaccine doses acquired and those eventually applied;

     

  3. Respect the calendar and vaccination prioritization established in the National Vaccination Policy, to avoid duplication;

     

  4. Implementation of preventive and control measures in accordance with the provisions issued by the Ministry of Health; and

     

  5. Guarantee the traceability of the vaccination process and share periodic reports as required by the Ministry of Health.

No further details have been released of how interested parties may individually participate, or even interact with the Mexican Government in the National Vaccination Plan.

Other relevant importation measures

On February 2, 2021, the Mexican President published a Decree that provides Customs measures to facilitate the importation of goods to combat the COVID outbreak.

The following Harmonized Tariff System codes were created:


DESCRIPTION  HTS CLASSIFICATION  UNIT OF QUANTITY  RATES OF DUTY 
Vaccine to combat the SARS-Cov2 Virus  3002.20.10  Kg  Free 
Oxygen tanks for medical purposes  7613.00.02  Number  Free 

Please consider that the aforementioned rates of duty will be applicable during the outbreak; when it ends, the goods will be subject to a rate of duty of 5% and 10%, respectively.

Relevant importation procedures by the Ministry of Health, a number of which have recently been relaxed, still need to be followed to import said goods.

COVID-19 continues to impact companies in all sectors of the economy.  Foley is here to help our clients effectively address the short-term and long-term impacts on their business interests, operations, and objectives. Foley provides insights and strategies across multiple industries and disciplines to provide timely perspective on the wide range of legal and business challenges that companies face conducting business while dealing with the impact of the coronavirus. Click here to stay up to date and ahead of the curve with our key publications addressing today’s challenges and tomorrow’s opportunities. To receive this content directly in your inbox, click here and submit the form. 

------------------------------------------------------

1 Mexico's National Health System is comprised of (i) the agencies and entities of the Public Administration, both federal and local, and the individuals or legal entities of the social (sic, undefined) and private sectors, who provide comprehensive (full service) health services; (ii) and  the mechanisms for coordinating actions to fulfill the right-to-health protection.

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.

Related Services